Effect of respiratory syncytial virus infection on regulated on activation, normal T-cells expressed and secreted production in a murine model of asthma
- PMID: 22253642
- PMCID: PMC3254891
- DOI: 10.3345/kjp.2011.54.11.456
Effect of respiratory syncytial virus infection on regulated on activation, normal T-cells expressed and secreted production in a murine model of asthma
Abstract
Purpose: Synthesis of regulated on activation, normal T-cells expressed and secreted (RANTES) in the airway has previously been shown to be elevated after respiratory syncytial virus (RSV) infection. However, since few studies have examined whether RSV-infected asthma patients express a higher level of RANTES than do normal individuals, we used a murine model of asthma to address this question.
Methods: We prepared Dermatophagoides farinae-sensitized mice as an asthma model, and then infected them with RSV and analyzed the changes in airway responsiveness and the cell populations and cytokine levels of bronchoalveolar lavage fluid.
Results: RANTES synthesis increased in response to RSV infection in both control mice and in asthma model (D. farinae) mice. However, there was no significant difference in the amount of RANTES produced following RSV infection between control and D. farinae mice. RSV infection affected neither interferon-γsynthesis nor airway responsiveness in either control or D. farinae mice.
Conclusion: RSV infection did not induce more RANTES in a murine model of asthma than in control mice.
Keywords: Animal models; Asthma; RANTES; Respiratory syncytial virus.
Figures






Similar articles
-
Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma.Ann Allergy Asthma Immunol. 2006 Jul;97(1):55-60. doi: 10.1016/S1081-1206(10)61370-1. Ann Allergy Asthma Immunol. 2006. PMID: 16892782
-
Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.Clin Exp Allergy. 2004 Aug;34(8):1307-13. doi: 10.1111/j.1365-2222.2004.02033.x. Clin Exp Allergy. 2004. PMID: 15298574
-
Induction of allergen-specific IL-2 responsiveness of lymphocytes after respiratory syncytial virus infection and prediction of onset of recurrent wheezing and bronchial asthma.J Allergy Clin Immunol. 1996 Oct;98(4):816-26. doi: 10.1016/s0091-6749(96)70131-8. J Allergy Clin Immunol. 1996. PMID: 8876558
-
Regulation of mite allergen-pulsed murine dendritic cells by respiratory syncytial virus.Am J Respir Crit Care Med. 2004 Feb 15;169(4):494-8. doi: 10.1164/rccm.200305-663OC. Epub 2003 Dec 4. Am J Respir Crit Care Med. 2004. PMID: 14656751
-
Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S66-74; discussion S74-5. doi: 10.1097/01.inf.0000053888.67311.1d. Pediatr Infect Dis J. 2003. PMID: 12671455 Review.
References
-
- Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59:469–478. - PubMed
-
- Anderson GP. Therapeutic prospects for early asthma. Med J Aust. 2002;177(Suppl):S66–S69. - PubMed
-
- Shaver JR, Zangrilli JG, Cho SK, Cirelli RA, Pollice M, Hastie AT, et al. Kinetics of the development and recovery of the lung from IgE-mediated inflammation: dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines. Am J Respir Crit Care Med. 1997;155:442–448. - PubMed
LinkOut - more resources
Full Text Sources